The antibody response to the glycan α-Gal correlates with COVID-19 disease symptoms
J. M. Urra, E. Ferreras-Colino, M. Contreras, C. M. Cabrera, I. G. Fernandez de Mera, M. Villar, A. Cabezas-Cruz, C. Gortazar, J. de la Fuente
This study examines the correlation between anti-α-Gal antibody levels and COVID-19 disease severity in patients compared to healthy controls.
bioRxiv · Jul 14, 2020Immunology